Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 1863 entries
View as:

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00587054 Org: User:
Start: 06/30/01 End: 05/31/11 Due: 05/31/12

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00004250 Org: User:
Start: 08/31/99 End: - Due: -

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

Phase: N/A Priority: Normal
NCT ID: NCT01649661 Org: User:
Start: 07/31/12 End: 01/25/23 Due: 01/25/24

Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00620139 Org: User:
Start: 03/31/05 End: 10/31/13 Due: 10/31/14

Female Cancer Patients' Preference For Sexual Health Interventions

Phase: N/A Priority: Normal
NCT ID: NCT01084642 Org: User:
Start: 03/04/10 End: 07/03/17 Due: 07/03/18

Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors

Phase: N/A Priority: Normal
NCT ID: NCT03114566 Org: User:
Start: 04/05/17 End: 02/02/21 Due: 02/02/22

Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00608452 Org: User:
Start: 07/31/95 End: 11/30/09 Due: 11/30/10

Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)

Phase: N/A Priority: Normal
NCT ID: NCT00562640 Org: User:
Start: 10/16/07 End: 08/03/21 Due: 08/03/22

Brain Irradiation and Tremelimumab in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02563925 Org: User:
Start: 09/18/15 End: 07/14/21 Due: 07/14/22

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02502786 Org: User:
Start: 07/31/15 End: 07/31/25 Due: 07/31/26

Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00387959 Org: User:
Start: 07/31/06 End: 04/30/14 Due: 04/30/15

Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02181829 Org: User:
Start: 07/31/14 End: 06/24/20 Due: 06/24/21

Multiple Therapies in Treating Patients With Advanced Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00040872 Org: User:
Start: 06/30/00 End: 01/31/07 Due: 01/31/08

A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03877055 Org: User:
Start: 03/13/19 End: 10/07/22 Due: 10/07/23

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Phase: N/A Priority: Normal
NCT ID: NCT00040898 Org: User:
Start: 01/31/01 End: - Due: -

Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00003737 Org: User:
Start: 01/31/99 End: 09/30/06 Due: 09/30/07

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Phase: N/A Priority: Normal
NCT ID: NCT06941480 Org: User:
Start: 08/31/25 End: 05/31/30 Due: 05/31/31

PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT02307630 Org: User:
Start: 11/30/14 End: 11/30/25 Due: 11/30/26

Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02803203 Org: User:
Start: 06/29/16 End: 03/01/22 Due: 03/01/23

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT01991379 Org: User:
Start: 11/30/13 End: 11/30/25 Due: 11/30/26

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06457919 Org: User:
Start: 06/04/24 End: 06/30/27 Due: 06/30/28

Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04401774 Org: User:
Start: 05/22/20 End: 05/22/26 Due: 05/22/27

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01745588 Org: User:
Start: 12/31/12 End: 12/31/25 Due: 12/31/26

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

Phase: N/A Priority: Normal
NCT ID: NCT03351348 Org: User:
Start: 11/16/17 End: 11/30/26 Due: 11/30/27

A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05207098 Org: User:
Start: 12/22/21 End: 12/31/26 Due: 12/31/27